BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8031035)

  • 1. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
    Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
    Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
    Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
    Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro.
    Colledge D; Locarnini S; Shaw T
    Hepatology; 1997 Jul; 26(1):216-25. PubMed ID: 9214473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
    Colledge D; Civitico G; Locarnini S; Shaw T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Colledge D; Wang YY; Locarnini S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2132-7. PubMed ID: 9687423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
    Civitico G; Wang YY; Luscombe C; Bishop N; Tachedjian G; Gust I; Locarnini S
    J Med Virol; 1990 Jun; 31(2):90-7. PubMed ID: 1696959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
    Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
    Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
    Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro.
    Civitico G; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 May; 40(5):1180-5. PubMed ID: 8723462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C; Pedersen J; Uren E; Locarnini S
    Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
    Fourel I; Saputelli J; Schaffer P; Mason WS
    J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
    Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
    Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture.
    Hung LF; Brumbaugh AE; Bhatia G; Marion PL; Hung PP; Norbeck DW; Plattner JJ; Robinson WS
    J Med Virol; 1991 Nov; 35(3):180-6. PubMed ID: 1804929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
    Schröder I; Holmgren B; Oberg M; Löfgren B
    Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
    Niu J; Wang Y; Dixon R; Bowden S; Qiao M; Einck L; Locarnini S
    Antiviral Res; 1993 Jun; 21(2):155-71. PubMed ID: 7687840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
    Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir.
    Dean J; Bowden S; Locarnini S
    Antiviral Res; 1995 May; 27(1-2):171-8. PubMed ID: 7486954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.